Wallonia is a world benchmark in the field of biotechnology. Our region is particularly recognized for and specialized in in-vitro and in-vivo diagnostics, cell therapy, immunology, biopharmacy, radiopharmaceutical applications and innovative medical equipment.

  • 140 companies including Biotech, Medtech, CRO, CMO, Distribution
  • 400 research units
  • 11,000 researchers
  • 5 universities (UCLouvain-ULB-ULg-UMons-UNamur)
  • Numerous prestigious technology institutes and partners and its main partners aim, through a Discover-Build-Measure-Learn methodology, to define a strong strategy for the biotech sector by supporting their non-core business.
The strategy is based on a five-pillar approach: Business Strategy – Corporate Finance – Subsidies & Funding – Expertise & Networking – Completion & Governance.

Belgium is Europe’s biotech leader with  its 23% of the total market value of all public European biotech companies. is the reference accelerator in the field of health biotechnology and medical technologies in Wallonia (Belgium).